Skip to main content

Table 2 MINORS for assessing the quality of included studies

From: Novel surgical approaches for treating myopic traction maculopathy: a meta-analysis

Methodological item for nonrandomized studies

Elwan et al. [32]

Wang et al. [13]

Shiraki et al. [35]

Wang et al. [34]

Iwaski et al. [33]

Xin et al. [31]

Tian et al. [27]

Ho et al. [26]

Zhu et al. [36]

1. A clearly stated aim

2

2

2

2

2

2

2

2

2

2. Inclusion of consecutive patients

2

2

2

2

2

2

2

2

2

3. Prospective collection of data

2

0

0

0

0

0

0

0

0

4. Endpoints appropriate to the aim of the study

2

2

2

2

2

2

2

2

1

5. Unbiased assessment of the study endpoint

1

1

1

1

1

1

1

1

1

6. Follow-up period appropriate to the aim of the study

2

2

2

2

2

2

2

2

2

7. Loss to follow up less than 5%

2

2

2

2

2

2

2

2

2

8. Prospective calculation of the study size

0

0

0

0

0

0

0

0

0

9. An adequate control group

2

2

2

2

2

2

2

2

1

10. Contemporary groups

2

1

2

2

2

2

2

2

1

11. Baseline equivalence of groups

2

2

2

2

2

2

2

2

2

12. Adequate statistical analyses

2

2

1

2

2

2

2

2

1

13. MINORS score

20

18

18

19

19

19

19

19

15

Back to article page

BMC Ophthalmology

ISSN: 1471-2415

Contact us